Regorafenib for osteosarcoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Jan 2021: Trial registered, NCT04698785
  2. 21 Jul 2021: Trial started, NCT04698785

The trials

NCT04698785: Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

State
Under way
Phase
Phase 2
People
36 planned
Started
21 Jul 2021
Primary completion
21 Jul 2026
Arms
Regorafenib and best supportive care
Results
None posted
  1. 7 Jan 2021: Trial registered
  2. 21 Jul 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Regorafenib 40 MG Oral Tablet, Stivarga, Treatment by regorafenib and best supportive care.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.